Our analysis of CEACAM1 expression on both unstimulated and stimulated TH and CD8+ cytotoxic T cells (CTLs) revealed that there was no difference between RRMS patients and healthy controls (Supplementary Fig. 5, Supplementary Tables 2 and 3). The gene discussed is CEACAM1; the disease is relapsing-remitting multiple sclerosis.